Both BH3 mimetics exerted dose-dependent cytotoxic activity (Figures 1A, B), which strongly connected to Bcl-2 and Mcl-1 expression in these tumor cells showing high expression of Bcl-2 or Mcl-1 on both RNA and protein levels (Figures 1C, D). The gene discussed is BCL2; the disease is neoplasm.